Market Closed -
Nasdaq
16:00:00 2024-06-28 EDT
5-day change
1st Jan Change
1.25
USD
-0.79%
+2.46%
-17.22%
OPKO Health, Inc.'s Equity Buyback announced on January 4, 2024, has closed with 55,145,031 shares, for $50 million.
The company closed its plan on January 9, 2024.
Earnings Flash (OPK) OPKO HEALTH Posts Q1 Revenue $173.7M, vs. Street Est of $183M
05-07
MT
Opko Health, Inc. Provides Earnings Guidance for the Second Quarter of 2024
05-07
CI
Transcript : OPKO Health, Inc., Q1 2024 Earnings Call, May 07, 2024
05-07
OPKO Health, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024
05-07
CI
Laboratory Corp of America to Acquire BioReference's Diagnostics Business Select Assets
03-28
MT
Transcript : OPKO Health, Inc. - Shareholder/Analyst Call
03-28
Entera Bio Announces Robust Pharmacokinetic Data for First-In-Class Oral Glp-2 Peptide Tablet Treatment for Patients with Short Bowel Syndrome
03-20
CI
Opko Health Insider Bought Shares Worth $444,300, According to a Recent SEC Filing
03-14
MT
Opko Health Insider Bought Shares Worth $463,750, According to a Recent SEC Filing
03-13
MT
Opko Health Insider Bought Shares Worth $559,380, According to a Recent SEC Filing
03-12
MT
Barrington Cuts Price Target on OPKO Health to $1.50 From $2, Maintains Outperform Rating
02-28
MT
Transcript : OPKO Health, Inc., Q4 2023 Earnings Call, Feb 27, 2024
02-27
Earnings Flash (OPK) OPKO HEALTH Reports Q4 Revenue $181.9M, vs. Street Est of $177.5M
02-27
MT
OPKO Health, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023
02-27
CI
Drugmakers deepen efforts to tap into booming market for obesity drugs
02-27
RE
Opko Health Insider Bought Shares Worth $991,700, According to a Recent SEC Filing
02-21
MT
HealthSnap, Inc. announced that it has received $24.999999 million in funding from a group of investors
02-20
CI
OPKO Health, Inc. Announces the Cessation of Alexis Borisy as Member of the Board of Directors and Member of Compensation Committee of the Board
02-09
CI
NextPlat Preparing to Launch Opko Health Store on Alibaba's Tmall Global Platform
02-05
MT
Opko Health Insider Bought Shares Worth $488,650, According to a Recent SEC Filing
01-19
MT
Opko Health Insider Bought Shares Worth $386,200, According to a Recent SEC Filing
01-18
MT
Opko Health Insider Bought Shares Worth $954,300, According to a Recent SEC Filing
01-16
MT
Opko Health Insider Bought Shares Worth $480,379, According to a Recent SEC Filing
01-11
MT
Transcript : OPKO Health, Inc. Presents at J.P. Morgan 42nd Annual Healthcare Conference 2024, Jan-10-2024 03:45 PM
01-10
OPKO Health Closes Private Offering of $230 Million Convertible Notes Due 2029
01-09
MT
Duration Auto. 2 months 3 months 6 months 9 months 1 year 2 years 5 years 10 years Max.
Period Day Week
More charts
OPKO Health, Inc. is a multinational biopharmaceutical and diagnostics company. The Company's diagnostics segment consists of the clinical laboratory operations of BioReference Health, LLC (BioReference), its point-of-care operations. Its pharmaceutical segment consists of the pharmaceutical operations in Chile, Mexico, Ireland, Israel, Spain, Ecuador, France, the United States, and its pharmaceutical research and development operations. Through BioReference, it operates specialized laboratory divisions, such as GenPath (Urology), GenPath (Oncology), and GenPath (Women's Health). It has two commercial stage pharmaceutical products and several pharmaceutical compounds and technologies in various stages of research and development for a range of indications and conditions, including Rayaldee, Rayaldee, Oxyntomodulin, Biologics, NGENLA Somatrogon, and Factor VIIa-CTP. It develops and manufactures specialty active pharmaceutical ingredients (APIs) through FineTech Pharmaceutical, Ltd.
More about the company
Last Close Price
1.25
USD
Average target price
4.25
USD
Spread / Average Target
+240.00%
Consensus
1st Jan change
Capi.
-17.22% 871M -20.01% 8.43B +69.46% 4.35B +9.54% 2.78B -2.10% 2.64B -56.54% 1.74B -16.69% 1.48B +17.87% 1.22B -49.60% 1.02B -21.78% 948M
Medical & Diagnostic Laboratories
+951% of historical performance
More than 20 years at your side
Our Experts are here for you
OUR EXPERTS ARE HERE FOR YOU
Monday - Friday 9am-12pm / 2pm-6pm GMT + 1